Shree Krishna Pharma

Borvig 2mg Injection contains Bortezomib, a proteasome inhibitor used to treat multiple myeloma and mantle cell lymphoma. It works by blocking proteasomes, which help break down proteins in cells, leading to cancer cell death. This injection is administered under medical supervision, usually through intravenous or subcutaneous routes. Common side effects include fatigue, nausea, diarrhea, and low blood cell counts. Always follow the doctor's dosage instructions for safe use.